A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, March 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,154 followers.

RT @biosimilarz: $PFE publishes p1 data on PF‑06439535 (bevacizumab #biosimilar), and things look pretty clean; https://t.co/jqwYncb5rr

$PFE publishes p1 data on PF‑06439535 (bevacizumab #biosimilar), and things look pretty clean; https://t.co/jqwYncb5rr

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.